PALI
Palisade Bio Inc
1.50$
+2.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -14.0% | +15.2% | – | – | – | -46.7% | +4.4% | -73.0% | -82.9% | -44.7% | +56.0% | +1,500.4% | +0.0% | -94.1% | -12.2% | -100.0% | – | +0.0% | -100.0% | – | |
| – | +0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +15.1% | -0.6% | -97.6% | -25.0% | +0.0% | |
| – | +4.0% | +15.2% | – | – | – | -46.7% | +4.4% | -73.0% | -82.9% | -44.7% | +56.0% | +1,500.4% | +380.8% | -98.8% | -1,048.4% | – | – | – | -101.2% | – | |
| – | +192.1% | +107.2% | +89.3% | -17.9% | +71.4% | -19.7% | -17.0% | +16.8% | +14.0% | +55.3% | +1.6% | -37.7% | -50.5% | +2.6% | -23.7% | -21.6% | +169.4% | +5.3% | +31.5% | +12.5% | |
| – | – | +86.6% | +64.1% | -4.2% | +31.7% | -11.9% | -27.3% | +23.7% | +70.7% | -27.2% | +14.8% | -27.0% | -34.8% | +103.9% | -14.8% | +50.2% | -5.8% | -29.2% | -6.5% | +35.7% | |
| – | +88.0% | -54.0% | +651.2% | -11.5% | +52.1% | -15.9% | -21.1% | +19.6% | +38.2% | +9.8% | +7.8% | -34.3% | -37.2% | +1.5% | +5.8% | +357.4% | -62.4% | -15.3% | +11.6% | +21.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -90.8% | -100.0% | – | – | +243.0% | -69.2% | +228.7% | +51,548.8% | +16.3% | +12.0% | -37.2% | -86.1% | -95.2% | +15.9% | +2,534.5% | +920.4% | -99.5% | +15.4% | -20.0% | -16.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -3,970.5% | – | -90.9% | -15,812.8% | – | – | +922.1% | -412.7% | – | -91.4% | -14.2% | +164.1% | -323.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.